Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery

Attachment of cytokines to magnetic nanoparticles has been developed as a system for controlled local drug release in cancer therapy. We studied the adsorption/release of murine interferon gamma (IFN-γ) on negatively charged magnetic nanoparticles prepared by three different methods, including copre...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 130; no. 2; pp. 168 - 174
Main Authors Mejías, Raquel, Costo, Rocío, Roca, Alejandro G., Arias, Cristina F., Veintemillas-Verdaguer, Sabino, González-Carreño, Teresita, del Puerto Morales, María, Serna, Carlos J., Mañes, Santos, Barber, Domingo F.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 10.09.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Attachment of cytokines to magnetic nanoparticles has been developed as a system for controlled local drug release in cancer therapy. We studied the adsorption/release of murine interferon gamma (IFN-γ) on negatively charged magnetic nanoparticles prepared by three different methods, including coprecipitation, decomposition in organic media, and laser pyrolysis. To facilitate IFN-γ adsorption, magnetic nanoparticles were surface modified by distinct molecules to achieve high negative charge at pH 7, maintaining small aggregate size and stability in biological media. We analyzed carboxylate-based coatings and studied the colloidal properties of the resulting dispersions. Finally, we incubated the magnetic dispersions with IFN-γ and determined optimal conditions for protein adsorption onto the particles, as well as the release capacity at different pH and as a function of time. Particles prepared by decomposition in organic media and further modified with dimercaptosuccinic acid showed the most efficient adsorption/release capacity. IFN-γ adsorbed on these nanoparticles would allow concentration of this protein or other biomolecules at specific sites for treatment of cancer or other diseases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2008.05.028